In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
Injection of a new gene therapy vector into the easily accessible vitreous transduced the entire retina and rescued disease phenotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, other studies showed that some specially engineered vectors, via directed evolution, can transduce the outer retina after being injected intravitreally.65,70”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [65]
In the citing paper
“preclinical and clinical studies have demonstrated dose-dependent inflammation, which can reduce efficacy and lead to dose-limiting toxicity (2–8)”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [8]
In the citing paper
“AAV2.7m8 was engineered from AAV2 via directed evolution in rodents, canines and nonhuman primates and includes a 10-amino acid insertion in loop IV of the AAV2 viral structural spike proteins (VP1-3), which has been shown to facilitate transit across the inner limiting membrane (ILM).4,16,17”
In the citing paper
“Additionally, the AAV2.7m8 capsid of ixo-vec was evolved in multiple species and selected for its robust transduction of retinal cells, including photoreceptors, ganglion cells, bipolar cells, optic nerve cells, Müller cells, ciliary epithelium and the iris pigment epithelium following intravitreal delivery.4,16,17,20”
In the citing paper
“Prior programs have attempted intravitreal delivery with gene therapy vectors with known limited ability to cross the ILM and ocular transduction capacity (e.g., AAV2-sFLT01).16,18,21”
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J.-J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 673
Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa
Busskamp, V., Duebel, J., Balya, D., Fradot, M., Viney, T. J., Siegert, S., Groner, A. C., Cabuy, E., Forster, V., Seeliger, M., et al. (2010) · Science · doi:10.1126/science.1190897 · Cited by 642
Jacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait
Wright, A. F., Chakarova, C. F., Abd El-Aziz, M. M., & Bhattacharya, S. S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2717 · Cited by 631
Lagali, P. S., Balya, D., Awatramani, G. B., Münch, T. A., Kim, D. S., Busskamp, V., Cepko, C. L., & Roska, B. (2008) · Nature Neuroscience · doi:10.1038/nn.2117 · Cited by 582
Zhong, L., Li, B., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R. W., Zolotukhin, I., Warrington, K. H., Weigel-Van Aken, K. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802866105 · Cited by 558
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
Maheshri, N., Koerber, J. T., Kaspar, B. K., & Schaffer, D. V. (2006) · Nature Biotechnology · doi:10.1038/nbt1182 · Cited by 538 · cited 2×
“As we have previously reported (48, 49), random mutagenesis libraries were generated by subjecting the resulting AAV2 Y444F cap to errorprone PCR, as described.”
MethodSelf-citationMüller, O. J., Kaul, F., Weitzman, M. D., Pasqualini, R., Arap, W., Kleinschmidt, J. A., & Trepel, M. (2003) · Nature Biotechnology · doi:10.1038/nbt856 · Cited by 410
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.-H., Chiodo, V., Pang, J.-J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A. S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.269 · Cited by 398
Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357
Self-citationNeural-vascular relationships in central retina of macaque monkeys (Macaca fascicularis)
Snodderly, D., Weinhaus, R., & Choi, J. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-04-01169.1992 · Cited by 334
Immune response to green fluorescent protein: implications for gene therapy
Stripecke, R., del Carmen Villacres, M., Skelton, D. C., Satake, N., Halene, S., & Kohn, D. B. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300951 · Cited by 333
Jacobson, S. G., Aleman, T. S., Cideciyan, A. V., Sumaroka, A., Schwartz, S. B., Windsor, E. A. M., Traboulsi, E. I., Heon, E., Pittler, S. J., Milam, A. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500646102 · Cited by 274
Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina
Petrs-Silva, H., Dinculescu, A., Li, Q., Deng, W.-T., Pang, J.-J., Min, S.-H., Chiodo, V., Neeley, A. W., Govindasamy, L., Bennett, A., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.234 · Cited by 267
Noninvasive, In Vivo Assessment of Mouse Retinal Structure Using Optical Coherence Tomography
Fischer, M. D., Huber, G., Beck, S. C., Tanimoto, N., Muehlfriedel, R., Fahl, E., Grimm, C., Wenzel, A., Remé, C. E., van de Pavert, S. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007507 · Cited by 251
Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey
Vandenberghe, L. H., Bell, P., Maguire, A. M., Cearley, C. N., Xiao, R., Calcedo, R., Wang, L., Castle, M. J., Maguire, A. C., Grant, R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002103 · Cited by 242
In vitro selection of viral vectors with modified tropism: the adeno-associated virus display
Perabo, L., Büning, H., Kofler, D. M., Ried, M. U., Girod, A., Wendtner, C. M., Enssle, J., & Hallek, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00123-0 · Cited by 229
Intravitreal injection of AAV2 transduces macaque inner retina
Yin, L., Greenberg, K., Hunter, J. J., Dalkara, D., Kolstad, K. D., Masella, B. D., Wolfe, R., Visel, M., Stone, D., Libby, R. T., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6250 · Cited by 212
Self-citationA myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
Yang, L., Jiang, J., Drouin, L. M., Agbandje-Mckenna, M., Chen, C., Qiao, C., Pu, D., Hu, X., Wang, D.-Z., Li, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813207106 · Cited by 210
Klimczak, R. R., Koerber, J. T., Dalkara, D., Flannery, J. G., & Schaffer, D. V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007467 · Cited by 210 · cited 1×
“This approach, which selected viruses for the ability to penetrate the retina and infect a therapeutically relevant cell, advances on previous work that selected AAV libraries in vitro (41, 42) or selected the virus in vivo for general localization to an organ after injection into the bloodstream (43, 44).”
BackgroundSelf-citationGray, S. J., Blake, B. L., Criswell, H. E., Nicolson, S. C., Samulski, R. J., & McCown, T. J. (2010) · Molecular Therapy · doi:10.1038/mt.2009.292 · Cited by 185
(2008) · PubMed Central · Cited by 183
Gambotto, A., Dworacki, G., Cicinnati, V, Kenniston, T., Steitz, J., Tüting, T., Robbins, P., & DeLeo, A. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301335 · Cited by 183
LiGluR restores visual responses in rodent models of inherited blindness
Caporale, N., Kolstad, K. D., Lee, T., Tochitsky, I., Dalkara, D., Trauner, D., Kramer, R., Dan, Y., Isacoff, E. Y., & Flannery, J. G. (2011) · Molecular Therapy · doi:10.1038/mt.2011.103 · Cited by 182
Molecular evolution of adeno-associated virus for enhanced glial gene delivery
Koerber, J. T., Klimczak, R., Jang, J.-H., Dalkara, D., Flannery, J. G., & Schaffer, D. V. (2009) · Molecular Therapy · doi:10.1038/mt.2009.184 · Cited by 181
Self-citationDNA Shuffling of Adeno-associated Virus Yields Functionally Diverse Viral Progeny
Koerber, J. T., Jang, J.-H., & Schaffer, D. V. (2008) · Molecular Therapy · doi:10.1038/mt.2008.167 · Cited by 181
Self-citationMin, S. H., Molday, L. L., Seeliger, M. W., Dinculescu, A., Timmers, A. M., Janssen, A., Tonagel, F., Tanimoto, N., Weber, B. H. F., Molday, R. S., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.002 · Cited by 174
Preclinical safety evaluation of AAV2-sFLT01— a gene therapy for age-related macular degeneration
MacLachlan, T. K., Lukason, M., Collins, M., Munger, R., Isenberger, E., Rogers, C., Malatos, S., DuFresne, E., Morris, J., Calcedo, R., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.258 · Cited by 166
Remodeling of cone photoreceptor cells after rod degeneration in rd mice
Lin, B., Masland, R. H., & Strettoi, E. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.11.022 · Cited by 158
Molday, L. L., Wu, W. W. H., & Molday, R. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706321200 · Cited by 147
Park, T. K., Wu, Z., Kjellström, S., Zeng, Y., Bush, R. A., Sieving, P. A., & Colosi, P. (2009) · Gene Therapy · doi:10.1038/gt.2009.61 · Cited by 146
Hellström, M., Ruitenberg, M. J., Pollett, M. A., Ehlert, E. M. E., Twisk, J., Verhaagen, J., & Harvey, A. R. (2009) · Gene Therapy · doi:10.1038/gt.2008.178 · Cited by 142
Rod-Derived Cone Viability Factor for Treating Blinding Diseases: From Clinic to Redox Signaling
Léveillard, T., & Sahel, J. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000866 · Cited by 141
Kjellström, S., Bush, R. A., Zeng, Y., Takada, Y., & Sieving, P. A. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0203 · Cited by 128
Evaluation of AAV-Mediated Expression of Chop2-GFP in the Marmoset Retina
Ivanova, E., Hwang, G.-S., Pan, Z., & Troilo, D. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5389 · Cited by 119
AAV-mediated photoreceptor transduction of the pig cone-enriched retina
Mussolino, C., della Corte, M., Rossi, S., Viola, F., Di Vicino, U., Marrocco, E., Neglia, S., Doria, M., Testa, F., Giovannoni, R., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.3 · Cited by 102
Janßen, A., Min, S.-H., Molday, L. L., Tanimoto, N., Seeliger, M. W., Hauswirth, W. W., Molday, R. S., & Weber, B. H. F. (2008) · Molecular Therapy · doi:10.1038/mt.2008.57 · Cited by 95
Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy
Chan, F., Bradley, A., Wensel, T. G., & Wilson, J. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403149101 · Cited by 92
Koerber, J. T., Maheshri, N., Kaspar, B. K., & Schaffer, D. V. (2006) · Nature Protocols · doi:10.1038/nprot.2006.93 · Cited by 88
Self-citationFunctional and Anatomic Consequences of Subretinal Dosing in the Cynomolgus Macaque
Nork, T. M. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.295 · Cited by 73
Bradshaw, K., George, N., Moore, A. T., & Trump, D. (1999) · Documenta Ophthalmologica · doi:10.1023/a:1002432919073 · Cited by 68
Lebherz, C., Maguire, A. M., Auricchio, A., Tang, W., Alemán, T. S., Wei, Z., Grant, R. L., Cideciyan, A. V., Jacobson, S. G., Wilson, J. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1141 · Cited by 68
Adeno-associated viral vectors for retinal gene transfer
Surace, E. M., & Auricchio, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(03)00052-1 · Cited by 47
Li, W., Kong, F., Li, X., Dai, X., Liu, X., Zheng, Q., Wu, R., Zhou, X., Lü, F., Chang, B., et al. (2009) · PubMed · Cited by 45
Structure of the vitread face of the monkey optic disc (Macacca mulatta)
Heegaard, S., Jensen, O. A., & Prause, J. U. (1988) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf02172971 · Cited by 29
Cited by
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
“For example, the CMV promoter has been shown to be silenced in the central nervous system (CNS) [16].”
BackgroundInfluentialA Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons
Tervo, D. G. R., Hwang, B.-Y., Viswanathan, S., Gaj, T., Lavzin, M., Ritola, K. D., Lindo, S., Michael, S., Kuleshova, E., Ojala, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.021 · Cited by 1,179
“However, the resulting increase in vector spread alone cannot explain the efficacy of retrograde transport, as other inserted 7-mer sequences disrupt heparin binding similarly but do not affect retrograde transport (Dalkara et al., 2013).”
BackgroundSelf-citationEngineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Deverman, B. E., Pravdo, P. L., Simpson, B. P., Kumar, S. R., Chan, K. Y., Banerjee, A., Wu, W.-L., Yang, B., Huber, N., Pasca, S. P., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3440 · Cited by 1,061
Metadata
- Authors
- Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V.
- Affiliations
- University of California, Berkeley (US)
- University of Rochester Medicine (US)
- Corresponding author
- Dalkara, Deniz
- Byrne, Leah C.
- Flannery, John G.
- Schaffer, David V.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2013-06-12
- Volume
- 5
- Issue
- 189
- Pages
- 189ra76-189ra76
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2160986529
- Cited by
- 734
- References
- 50
- Citations by year
- 2026: 49 · 2025: 67 · 2024: 60 · 2023: 51 · 2022: 60 · 2021: 85 · 2020: 68 · 2019: 61 · 2018: 49 · 2017: 47 · 2016: 44 · 2015: 45 · 2014: 39 · 2013: 7
- FWCI
- 29.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY013533, PN2EY018241, R01EY022975)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus, intravitreal injection, retinal degeneration, X-linked retinoschisis, Leber congenital amaurosis, photoreceptors, retinal pigment epithelium, gene therapy
- MeSH terms
- Dependovirus, Animals, Models, Biological, Photoreceptor Cells, Retina, Retinal Degeneration, Genetic Therapy, Retinoschisis, Mice, Retinal Pigment Epithelium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.